Zoetis Inc
NYSE:ZTS

Watchlist Manager
Zoetis Inc Logo
Zoetis Inc
NYSE:ZTS
Watchlist
Price: 176.96 USD 0.14% Market Closed
Market Cap: 79.8B USD
Have any thoughts about
Zoetis Inc?
Write Note

Zoetis Inc
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zoetis Inc
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
Zoetis Inc
NYSE:ZTS
Effect of Foreign Exchange Rates
-$22m
CAGR 3-Years
N/A
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Effect of Foreign Exchange Rates
$34m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Effect of Foreign Exchange Rates
$88m
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
8%
Pfizer Inc
NYSE:PFE
Effect of Foreign Exchange Rates
-$79m
CAGR 3-Years
-329%
CAGR 5-Years
-14%
CAGR 10-Years
-14%
Merck & Co Inc
NYSE:MRK
Effect of Foreign Exchange Rates
$260m
CAGR 3-Years
38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eli Lilly and Co
NYSE:LLY
Effect of Foreign Exchange Rates
$261.1m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zoetis Inc
Glance View

Market Cap
79.9B USD
Industry
Pharmaceuticals

Zoetis Inc. is a leading global animal health company dedicated to advancing animal care through innovative solutions that enhance the well-being and productivity of livestock and companion animals. Established in 1952 as a former division of the pharmaceutical giant Pfizer, Zoetis transitioned into its standalone identity in 2013 and has since carved out a significant niche in the growing market for animal health products. With a diverse portfolio that includes vaccines, parasiticides, and diagnostic tools, the company serves farmers, veterinarians, and pet owners, contributing to the health of food-producing animals and pets alike. The robust demand for high-quality animal health products—driven by increasing global food consumption and a growing pet population—positions Zoetis for sustainable growth and offers investors a compelling opportunity. Financially, Zoetis has demonstrated consistent revenue growth, leveraging its strong market presence and commitment to research and development. The company's strategic investments in new technologies and targeted acquisitions have strengthened its position in key market segments. With a focus on driving innovation and addressing changing consumer needs, Zoetis is poised to benefit from emerging trends such as increased attention to food safety and animal welfare. For investors, this translates to a resilient business model with solid long-term prospects, backed by a proven leadership team and a commitment to maintaining a competitive edge through continuous advancement in animal health solutions.

ZTS Intrinsic Value
119.41 USD
Overvaluation 33%
Intrinsic Value
Price

See Also

What is Zoetis Inc's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-22m USD

Based on the financial report for Sep 30, 2024, Zoetis Inc's Effect of Foreign Exchange Rates amounts to -22m USD.

What is Zoetis Inc's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 5Y
-34%

Over the last year, the Effect of Foreign Exchange Rates growth was -69%.

Back to Top